A synthetic peptide for use as a blocking control in assays to test for specificity of MAGEA4 antibody, Alternative Names: MAGEA4 control peptide, MAGEA4 antibody Blocking Peptide, Anti-MAGEA4 Blocking Peptide, Melanoma Antigen Family A 4 Blocking Peptide, MAGE-41 Blocking Peptide, MAGE-X2 Blocking Peptide, MAGE4 Blocking Peptide, MAGE4A Blocking Peptide, MAGE4B Blocking Peptide, MGC21336 Blocking Peptide, MAGEA4, MAGEA-4, MAGEA 4, MAGEA-4 Blocking Peptide, MAGEA 4 Blocking Peptide
MAGEA4
Reaktivität: Human
Wirt: Synthetic
BP, BI
Sodium azide
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
MAGEA4
(Melanoma Antigen Family A, 4 (MAGEA4))
Synonyme
Mage-a4 Peptide, MAGEA4 Peptide, CT1.4 Peptide, MAGE-41 Peptide, MAGE-X2 Peptide, MAGE4 Peptide, MAGE4A Peptide, MAGE4B Peptide, melanoma antigen, family A, 4 Peptide, MAGE family member A4 Peptide, Magea4 Peptide, MAGEA4 Peptide
Hintergrund
MAGEA4 is a member of the MAGEA family. The members of this family are proteins with 50 to 80 % sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita.